Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
The University of Würzburg has shed light on the intricate mechanisms of insulin production in fruit flies, revealing surprising parallels with human physiology. This study offers crucial insights into how insulin-producing cells respond to metabolic changes, with potential implications for understanding and treating diabetes.
The gap in the long process of progressing a novel scientific insight into a new medicine is often called “the valley of death”. Read below to understand how the strategic alliance between University of Oxford and Novo Nordisk is aiming to combat type 2 diabetes by bridging this gap.
Chester Medical school shed light on the link between obesity and diabetes, the challenge facing patients with ‘Diabesity’ and the research contribution of the school in solving this problem
Prof Dr Freimut Schliess, Director of Science & Innovation at Profil Institut für Stoffwechselforschung GmbH explains the important role of innovation when it comes to healthy living and active ageing, including his thoughts on the diabetes paradigm
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Kimberley Hanson, Director of Federal Affairs at Diabetes Canada argues that the country urgently needs a national strategy to tackle the diabetes epidemic
Kristoffer From, CEO of Liva Healthcare and Simon Pickup, UK Managing Director at Liva Healthcare share their thoughts on why obesity is key to tackling the root cause of Type 2 diabetes
Candice Ward, Lead CDEP Educator from Cambridge Diabetes Education Programme (CDEP) details online diabetes competency training, including the importance of improving standards and reducing variation
A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna
CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
John J. Nolan, Stefano Del Prato, Juleen R. Zierath from the European Association for the Study of Diabetes e.V. present their approach to address the pandemic of diabetes in Europe today
